Acadia Healthcare Company Inc to Post FY2018 Earnings of $2.27 Per Share, Jefferies Financial Group Forecasts (ACHC)

Share on StockTwits

Acadia Healthcare Company Inc (NASDAQ:ACHC) – Equities researchers at Jefferies Financial Group cut their FY2018 earnings estimates for Acadia Healthcare in a research note issued to investors on Monday, November 5th. Jefferies Financial Group analyst B. Tanquilut now expects that the company will earn $2.27 per share for the year, down from their previous estimate of $2.52. Jefferies Financial Group currently has a “Buy” rating and a $47.00 price target on the stock. Jefferies Financial Group also issued estimates for Acadia Healthcare’s Q4 2018 earnings at $0.50 EPS and FY2019 earnings at $2.59 EPS.

Acadia Healthcare (NASDAQ:ACHC) last posted its quarterly earnings results on Monday, November 5th. The company reported $0.55 earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.64 by ($0.09). The business had revenue of $760.90 million for the quarter, compared to the consensus estimate of $760.46 million. Acadia Healthcare had a return on equity of 7.93% and a net margin of 7.52%. The company’s quarterly revenue was up 6.2% on a year-over-year basis. During the same period last year, the firm earned $0.58 earnings per share.

ACHC has been the subject of a number of other reports. Zacks Investment Research raised shares of Acadia Healthcare from a “hold” rating to a “buy” rating and set a $48.00 price target for the company in a research note on Tuesday, July 24th. Mizuho set a $37.00 price target on shares of Acadia Healthcare and gave the stock a “hold” rating in a research note on Tuesday, August 28th. Craig Hallum downgraded shares of Acadia Healthcare from a “buy” rating to a “hold” rating in a research note on Wednesday, October 17th. They noted that the move was a valuation call. Cantor Fitzgerald reissued a “hold” rating and set a $39.00 price target on shares of Acadia Healthcare in a research note on Thursday, October 18th. Finally, ValuEngine raised shares of Acadia Healthcare from a “sell” rating to a “hold” rating in a research note on Friday, October 26th. Eight analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. The stock currently has an average rating of “Hold” and an average target price of $43.11.

ACHC opened at $39.00 on Wednesday. The company has a quick ratio of 1.24, a current ratio of 1.24 and a debt-to-equity ratio of 1.20. The company has a market cap of $3.95 billion, a P/E ratio of 16.96, a price-to-earnings-growth ratio of 1.60 and a beta of 0.22. Acadia Healthcare has a fifty-two week low of $26.92 and a fifty-two week high of $45.35.

Several institutional investors have recently added to or reduced their stakes in ACHC. Wells Fargo & Company MN boosted its holdings in shares of Acadia Healthcare by 52.4% in the first quarter. Wells Fargo & Company MN now owns 34,769 shares of the company’s stock valued at $1,362,000 after buying an additional 11,951 shares during the period. UBS Group AG boosted its holdings in shares of Acadia Healthcare by 88.6% in the first quarter. UBS Group AG now owns 76,738 shares of the company’s stock valued at $3,007,000 after buying an additional 36,045 shares during the period. Cubist Systematic Strategies LLC acquired a new position in shares of Acadia Healthcare in the first quarter valued at approximately $255,000. Legal & General Group Plc boosted its holdings in shares of Acadia Healthcare by 20.9% in the first quarter. Legal & General Group Plc now owns 93,441 shares of the company’s stock valued at $3,661,000 after buying an additional 16,126 shares during the period. Finally, Royal Bank of Canada boosted its holdings in shares of Acadia Healthcare by 39.3% in the first quarter. Royal Bank of Canada now owns 210,313 shares of the company’s stock valued at $8,240,000 after buying an additional 59,289 shares during the period.

In other Acadia Healthcare news, Director Reeve B. Waud sold 41,865 shares of the company’s stock in a transaction that occurred on Thursday, November 1st. The shares were sold at an average price of $45.00, for a total value of $1,883,925.00. Following the completion of the sale, the director now owns 14,213 shares of the company’s stock, valued at $639,585. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 2.50% of the stock is currently owned by corporate insiders.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities, and outpatient behavioral healthcare facilities to serve the behavioral health and recovery needs of communities. The company operates acute inpatient psychiatric facilities, which offer evaluation and crisis stabilization of patients with severe psychiatric diagnoses; specialty treatment facilities, including residential recovery facilities, eating disorder facilities, and comprehensive treatment centers that provide continuum care for adults with addictive disorders and co-occurring mental disorders; and residential treatment centers, which treat patients with behavioral disorders in a non-hospital setting, including outdoor programs.

Featured Story: Trading Strategy Examples and Plans

Earnings History and Estimates for Acadia Healthcare (NASDAQ:ACHC)

Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply